glp 1 for alcohol use GLP-1 plus therapy can reduce heavy drinking GLP-1 RAs may reduce alcohol-related

The study was a meta-analysis that included 21 trials (10 PIONEER and 11 SUSTAIN trials) involving 12,260 semaglutide users and 14,176 comparators

If pancreatitis is suspected (severe, persistent abdominal pain, particularly if radiating to the back, accompanied by nausea and vomiting), the GLP-1 medication should be discontinued immediately and urgent medical assessment sought

The Core Benefits of Microdosing Liver and Cardiovascular Protection A 72-week trial found 40% of patients achieved resolution of fatty liver disease without worsening fibrosis. In animal models, GLP-1s suppress fat production in the liver and reduce inflammation. Tirzepatide at low doses showed particularly strong cardiovascular benefits, with meaningful improvements across multiple lipid markers linked to heart disease risk. Cholesterol storage forms increased far less with tirzepatide, and harmful lipids like ceramides showed minimal increase compared to placebo

Effects of glucagon-like peptide-1(736)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

At the head of that table